Osaic Holdings’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Buy
10,745
+245
+2% +$6.11K ﹤0.01% 4258
2026
Q2
$255K Buy
10,500
+8,472
+418% +$144K ﹤0.01% 4230
2026
Q1
$31.4K Buy
2,028
+24
+1% +$398 ﹤0.01% 5694
2025
Q4
$38K Buy
2,004
+270
+16% +$3.88K ﹤0.01% 5427
2025
Q3
$16K Sell
1,734
-8
-0.5% -$83 ﹤0.01% 6081
2025
Q2
$19.8K Buy
1,742
+467
+37% +$5.05K ﹤0.01% 5715
2025
Q1
$15.1K Buy
1,275
+462
+57% +$7.73K ﹤0.01% 5543
2024
Q4
$15.3K Sell
813
-484
-37% -$11.1K ﹤0.01% 5519
2024
Q3
$29.1K Buy
1,297
+14
+1% +$317 ﹤0.01% 5125
2024
Q2
$26.8K Buy
+1,283
New +$20K ﹤0.01% 5139
2022
Q4
– Sell
-1,000
Closed -$13K – 7357
2022
Q3
$13K Buy
+1,000
New +$15.8K ﹤0.01% 5872

Other funds holding NRIX

Osaic Holdings's NRIX Position: Q3 2026 in Review

Osaic Holdings increased its Nurix Therapeutics (NRIX) stake by 2.3% in Q3 2026, buying an estimated $6.11K and bringing the position to 10,745 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #4258.

Osaic Holdings first reported a position in NRIX in Q3 2022 and has held it in 11 quarters since. 234 funds tracked by Wall St. Rank hold NRIX as of Q3 2026.

  • Osaic Holdings held 10,745 shares of Nurix Therapeutics worth $255K as of Q3 2026.
  • Osaic Holdings bought 245 Nurix Therapeutics shares in Q3 2026, an estimated $6.11K.
  • Nurix Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #4258 holding.
  • Osaic Holdings first reported a position in Nurix Therapeutics in Q3 2022 and has held it in 11 quarters since.
  • 234 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.